• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑啡肽、应激和抑郁。

Dynorphin, stress, and depression.

机构信息

Behavioral Genetics Laboratory, Department of Psychiatry, Harvard Medical School, McLean Hospital, MRC 217, 115 Mill Street, Belmont, MA 02478, USA.

出版信息

Brain Res. 2010 Feb 16;1314:56-73. doi: 10.1016/j.brainres.2009.09.074. Epub 2009 Sep 24.

DOI:10.1016/j.brainres.2009.09.074
PMID:19782055
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2819644/
Abstract

Stress is most often associated with aversive states. It rapidly induces the release of hormones and neuropeptides including dynorphin, which activates kappa opioid receptors (KORs) in the central and peripheral nervous systems. In animal models, many aversive effects of stress are mimicked or exacerbated by stimulation of KORs in limbic brain regions. Although KOR signaling during acute stress may increase physical ability (by producing analgesia) and motivation to escape a threat (by producing aversion), prolonged KOR signaling in response to chronic or uncontrollable stress can lead to persistent expression of behavioral signs that are characteristic of human depressive disorders (i.e., "prodepressive-like" signs). Accumulating evidence suggests that KORs contribute to the progressive amplification (sensitization) of stress-induced behaviors that occurs with repeated exposure to stress. Many of the aversive effects of stress are blocked by KOR antagonists, suggesting that these agents may have potential as therapeutics for stress-related conditions such as depression and anxiety disorders. This review summarizes current data on how KOR systems contribute to the acute (rapid), delayed, and cumulative molecular and behavioral effects of stress. We focus on behavioral paradigms that provide insight on interactions between stress and KOR function within each of these temporal categories. Using a simplified model, we consider the time course and mechanism of KOR-mediated effects in stress and suggest future directions that may be useful in determining whether KOR antagonists exert their therapeutic effects by preventing the development of stress-induced behaviors, the expression of stress-induced behaviors, or both.

摘要

压力通常与厌恶状态有关。它会迅速释放激素和神经肽,包括强啡肽,后者激活中枢和外周神经系统中的κ阿片受体(KOR)。在动物模型中,应激的许多厌恶效应通过刺激边缘脑区域的 KOR 来模拟或加剧。尽管急性应激期间的 KOR 信号可能会增加身体能力(通过产生镇痛作用)和逃避威胁的动机(通过产生厌恶作用),但对慢性或不可控应激的延长 KOR 信号会导致持久表达与人类抑郁障碍特征一致的行为迹象(即“类抑郁样”迹象)。越来越多的证据表明,KOR 有助于在反复暴露于应激时发生的应激诱导行为的渐进放大(敏化)。许多应激的厌恶效应被 KOR 拮抗剂阻断,这表明这些药物可能具有治疗与应激相关的疾病(如抑郁症和焦虑症)的潜力。这篇综述总结了目前关于 KOR 系统如何导致应激的急性(快速)、延迟和累积分子和行为效应的资料。我们专注于提供有关应激和 KOR 功能之间相互作用的见解的行为范例,这些范例适用于每个时间类别。使用简化的模型,我们考虑了 KOR 介导的应激效应的时间过程和机制,并提出了未来的方向,这可能有助于确定 KOR 拮抗剂是否通过预防应激诱导行为的发展、应激诱导行为的表达或两者兼而有之来发挥其治疗作用。

相似文献

1
Dynorphin, stress, and depression.脑啡肽、应激和抑郁。
Brain Res. 2010 Feb 16;1314:56-73. doi: 10.1016/j.brainres.2009.09.074. Epub 2009 Sep 24.
2
Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials.用于精神疾病的κ-阿片受体拮抗剂:从实验室到临床试验
Depress Anxiety. 2016 Oct;33(10):895-906. doi: 10.1002/da.22500.
3
Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats.外侧杏仁核中的κ阿片受体信号调节大鼠的条件性恐惧和焦虑。
Biol Psychiatry. 2011 Sep 1;70(5):425-33. doi: 10.1016/j.biopsych.2011.03.017. Epub 2011 Apr 30.
4
The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.强啡肽/κ 阿片系统作为应激诱导和促成瘾行为的调节剂。
Brain Res. 2010 Feb 16;1314:44-55. doi: 10.1016/j.brainres.2009.08.062. Epub 2009 Aug 28.
5
Role of kappa-opioid receptors in stress and anxiety-related behavior.κ-阿片受体在应激和焦虑相关行为中的作用。
Psychopharmacology (Berl). 2013 Oct;229(3):435-52. doi: 10.1007/s00213-013-3195-5. Epub 2013 Jul 9.
6
Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake.应激通过在腹侧纹状体释放内源性强啡肽来产生厌恶感并增强可卡因的奖赏效应,从而局部刺激 5-羟色胺再摄取。
J Neurosci. 2012 Dec 5;32(49):17582-96. doi: 10.1523/JNEUROSCI.3220-12.2012.
7
The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.压力中的烦躁不安成分是由强啡肽κ-阿片系统的激活所编码的。
J Neurosci. 2008 Jan 9;28(2):407-14. doi: 10.1523/JNEUROSCI.4458-07.2008.
8
Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.强啡肽/κ阿片受体系统在乙醇动机效应中的作用
Alcohol Clin Exp Res. 2017 Aug;41(8):1402-1418. doi: 10.1111/acer.13406. Epub 2017 Jun 5.
9
Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.应激诱导的尼古丁偏好恢复需要基底外侧杏仁核中的强啡肽/κ阿片样物质活性。
J Neurosci. 2016 Sep 21;36(38):9937-48. doi: 10.1523/JNEUROSCI.0953-16.2016.
10
Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder.κ 阿片受体在重性抑郁障碍的发病机制和治疗中的作用
Handb Exp Pharmacol. 2022;271:493-524. doi: 10.1007/164_2020_432.

引用本文的文献

1
Mechanistic intersections between migraine and major depressive disorder.偏头痛与重度抑郁症之间的机制交叉点。
J Headache Pain. 2025 Jul 9;26(1):157. doi: 10.1186/s10194-025-02097-x.
2
G Protein Inactivation as a Mechanism for Addiction Treatment.G蛋白失活作为成瘾治疗的一种机制。
Biol Psychiatry. 2025 Apr 4. doi: 10.1016/j.biopsych.2025.03.021.
3
A comprehensive review on the impact of polyphenol supplementation and exercise on depression and brain function parameters.关于补充多酚和运动对抑郁症及脑功能参数影响的综合综述。
Behav Brain Funct. 2025 Mar 26;21(1):10. doi: 10.1186/s12993-025-00273-2.
4
A New Trick of Old Dogs: Can Kappa Opioid Receptor Antagonist Properties of Antidepressants Assist in Treating Treatment-Resistant Depression (TRD)?老药新用:抗抑郁药的κ阿片受体拮抗剂特性能否助力治疗难治性抑郁症(TRD)?
Pharmaceuticals (Basel). 2025 Feb 3;18(2):208. doi: 10.3390/ph18020208.
5
Opioid receptor signaling throughout ontogeny: Shaping neural and behavioral trajectories.阿片受体信号在整个个体发育过程中的作用:塑造神经和行为轨迹。
Neurosci Biobehav Rev. 2025 Mar;170:106033. doi: 10.1016/j.neubiorev.2025.106033. Epub 2025 Jan 31.
6
Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits.丁丙诺啡的药效学:理解丁丙诺啡临床益处的桥梁。
Drugs. 2025 Feb;85(2):215-230. doi: 10.1007/s40265-024-02128-y. Epub 2025 Jan 28.
7
G protein Inactivation as a Mechanism for Addiction Treatment.G蛋白失活作为成瘾治疗的一种机制。
bioRxiv. 2024 Dec 17:2024.12.16.628727. doi: 10.1101/2024.12.16.628727.
8
Emerging medications and pharmacological treatment approaches for substance use disorders.物质使用障碍的新兴药物及药物治疗方法。
Pharmacol Biochem Behav. 2025 Mar;248:173952. doi: 10.1016/j.pbb.2024.173952. Epub 2024 Dec 22.
9
Discovery of Potent Kappa Opioid Receptor Agonists Derived from Akuammicine.从阿枯米辛衍生出的强效κ阿片受体激动剂的发现。
J Med Chem. 2024 Dec 12;67(23):20842-20857. doi: 10.1021/acs.jmedchem.4c00736. Epub 2024 Nov 20.
10
The Neurocircuitry of Substance Use Disorder, Treatment, and Change: A Resource for Clinical Psychiatrists.物质使用障碍的神经回路:临床精神科医生的资源。
Am J Psychiatry. 2024 Nov 1;181(11):958-972. doi: 10.1176/appi.ajp.20231023. Epub 2024 Oct 9.

本文引用的文献

1
Dissociation of the opioid receptor mechanisms that control mechanical and heat pain.控制机械性疼痛和热痛的阿片受体机制的解离。
Cell. 2009 Jun 12;137(6):1148-59. doi: 10.1016/j.cell.2009.04.019.
2
Kappa-opioid ligands in the study and treatment of mood disorders.κ-阿片样物质配体在情绪障碍研究与治疗中的应用
Pharmacol Ther. 2009 Sep;123(3):334-43. doi: 10.1016/j.pharmthera.2009.05.008. Epub 2009 Jun 2.
3
Retrograde opioid signaling regulates glutamatergic transmission in the hypothalamus.逆向阿片类信号传导调节下丘脑的谷氨酸能传递。
J Neurosci. 2009 Jun 3;29(22):7349-58. doi: 10.1523/JNEUROSCI.0381-09.2009.
4
30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.强啡肽30年研究——对其在神经精神疾病中功能的新见解
Pharmacol Ther. 2009 Sep;123(3):353-70. doi: 10.1016/j.pharmthera.2009.05.006. Epub 2009 May 28.
5
Psychobiology and molecular genetics of resilience.复原力的心理生物学与分子遗传学
Nat Rev Neurosci. 2009 Jun;10(6):446-57. doi: 10.1038/nrn2649.
6
Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: further studies on pain-depressed behavior.疼痛与镇痛相关操作对大鼠颅内自我刺激的影响:对疼痛抑制行为的进一步研究。
Pain. 2009 Jul;144(1-2):170-7. doi: 10.1016/j.pain.2009.04.010. Epub 2009 May 10.
7
Peptide kappa opioid receptor ligands: potential for drug development.肽κ阿片受体配体:药物开发潜力
AAPS J. 2009 Jun;11(2):312-22. doi: 10.1208/s12248-009-9105-4. Epub 2009 May 9.
8
The influence of stress hormones on fear circuitry.应激激素对恐惧神经回路的影响。
Annu Rev Neurosci. 2009;32:289-313. doi: 10.1146/annurev.neuro.051508.135620.
9
Endogenous kappa opioid activation mediates stress-induced deficits in learning and memory.内源性κ阿片类物质激活介导应激诱导的学习和记忆缺陷。
J Neurosci. 2009 Apr 1;29(13):4293-300. doi: 10.1523/JNEUROSCI.6146-08.2009.
10
Brain stress systems in the amygdala and addiction.杏仁核中的脑应激系统与成瘾
Brain Res. 2009 Oct 13;1293:61-75. doi: 10.1016/j.brainres.2009.03.038. Epub 2009 Mar 28.